Paul J Hauptman
Overview
Explore the profile of Paul J Hauptman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
2056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Zoubaidi L, Vinsdata N, Heidel R, Hauptman P
JAMA Netw Open
. 2025 Jan;
8(1):e2457307.
PMID: 39883467
No abstract available.
2.
Vinsdata N, Heidel R, Heidel R, Hauptman P
Am J Med
. 2025 Jan;
PMID: 39755135
Background: A wide array of products in the category of complementary or alternative medicine for cardiovascular disease and prevention are readily available on online retail platforms. However, a critical assessment...
3.
Hack J, Wingate S, Zolty R, Rich M, Hauptman P
Am J Med
. 2024 Sep;
138(1):25-33.e14.
PMID: 39265879
While there has been a decline in the use of digoxin in patients with heart failure and atrial fibrillation, acute and chronic digoxin toxicity remains a significant clinical problem. Digoxin's...
4.
Wheeler J, Heidel R, Dong A, Pleines K, Hauptman P
Circ Cardiovasc Qual Outcomes
. 2023 Oct;
16(10):e009987.
PMID: 37847754
Background: The burden from medication costs for treating heart failure can be financially toxic for uninsured/underinsured patients and their families. Prescription discount cards, which offer cash price reductions, may decrease...
5.
Enard K, Coleman A, Yakubu R, Butcher B, Tao D, Hauptman P
J Am Heart Assoc
. 2023 Jan;
12(3):e026590.
PMID: 36695317
Background Prior research suggests an association between clinical outcomes in heart failure (HF) and social determinants of health (SDoH). Because providers should identify and address SDoH in care delivery, we...
6.
Edwards J, Mosman A, Hauptman P, Lee T, Philipneri M, Farahmand F, et al.
Hemodial Int
. 2022 Nov;
27(1):45-54.
PMID: 36411729
Introduction: People with end-stage renal disease on hemodialysis are at increased risk for death due to arrhythmia associated with the prolonged interdialytic interval that typically spans the weekend, with bradycardia...
7.
Kapelios C, Lund L, Benson L, Dahlstrom U, Rosano G, Hauptman P, et al.
Eur Heart J Cardiovasc Pharmacother
. 2021 Dec;
8(8):756-767.
PMID: 34921603
Aims: Digoxin is included in some heart failure (HF) guidelines but controversy persists about the true role for and impact of treatment with this drug, particularly in the absence of...
8.
9.
Greene S, Adusumalli S, Albert N, Hauptman P, Rich M, Heidenreich P, et al.
J Card Fail
. 2020 Dec;
27(1):2-19.
PMID: 33289664
Heart failure (HF) remains a leading cause of mortality and morbidity and a primary driver of health care resource use in the United States. As such, there continues to be...
10.